GREENOVATION - Pharmaceutical Protein Production in Moss

DQS-Quality Management

A Novel Expression Platform for Pharmaceutical Proteins

A Noval Expression Platform for Pharmaceutical Proteins

Our core competence

is the effective optimization and production of pharmaceutically highly-efficient glycoproteins in contained photo bioreactors of the wave type.

The production platform

is based on bryotechnology (bryophytes = mosses), developed by greenovation. In this process mosses are genetically modified in a way that enables them to reproduce exactly the desired protein, for example antibodies to fight cancer.

Our main focus

is the production and optimization of therapeutic proteins for different indications. We have already supplied our products to global customers for preclinical studies and end of 2013 with material for clinical testing.